Glenmark gets tentative FDA nod for generic TecfideraTecfidera capsules, 120 mg and 240 mg had a market value of approximately $3.7 billion for the 12 months ended in August 2019. Amneal launches generic InvegaPaliperidone extended-release tablets had a market value of approximately $373 million for the 12 months ended July 31. Alembic intros generic Lumigan Pfenex gets FDA nod for potential Forteo generic Forteo had a global market value of $1.6 billion in 2018. Fresenius Kabi introduces generic Faslodex Fresenius Kabi developed its fulvestrant injection prefilled syringe to be stable at room temperature, so that it doesn't require refrigeration. Alembic launches generic Optivar Alembic's azelastine ophthalmic solution 0.05% is provided as 6mL in a sterile dispensing bottle. MedicaSafe partners with Amneal on generic Suboxone monitoring MedicaSafe will combine Amneal's generic of Suboxone (buprenorphine and naloxone) with its smart medication systems to treat opioid dependence. Perrigo relaunches generic Transderm Scop Transderm Scop and generics had a market value of roughly $147 million for the 12 months ending August 2019. Lannett enters into distribution agreement for generic Advair Diskus Under the agreement, Lanett will begin U.S. distribution of Respirent’s generic once the product receives the Food and Drug Administration’s approval. Pfizer reportedly to launch Avastin biosimilar in December Pfizer is planning to launch its Avastin biosimilar, Zirabev, on Dec. 31, according to a First Previous 158 159 160 161 162 Next Last